AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 21386036
Drug: Atorvastatin 5
RxNorm normalized name: amlodipine-atorvastatin 5 mg-80 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 5 mg/5 mg and Ezetimibe
Trial: 20423469
Drug: Dietetic counselling
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dietetic counselling (by regular home visits and telephone calls) and oral nutritional supplementation for three months after surgery
Trial: 12587819
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose i.v. cyclophosphamide (200‐400 mg per month) and prednisone (mean dose 20.5 mg per day)
Trial: 12587819
Drug: Prednisone (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisone (mean dose 20.5 mg per day) only or with antimalarials
Trial: 11099587
Drug: Intramuscular (IM)
RxNorm normalized name: intramuscular immunoglobulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular (IM) dexamethasone (0.6 mg/kg, maximum 8 mg)
Trial: 11099587
Drug: Oral (PO)
RxNorm normalized name: Oral Film
DrugBank: Sodium citrate (DB09154)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral (PO) dexamethasone (0.6 mg/kg, maximum 8 mg)
Trial: 10988282
Drug: Losartan (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan (50 mg once daily)
Trial: 12241832
Drug: Captopril (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril (50 mg three times daily)
Trial: 3532694
Drug: i.v. diazoxide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. diazoxide (75-150 mg bolus injections)
Trial: 3532694
Drug: i.m. dihydralazine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.m. dihydralazine (6-12.5 mg bolus injections)
Trial: 3532694
Drug: Initial treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Initial treatment with furosemide i.v.
Trial: 11314240
Drug: Topical calcipotriol
RxNorm normalized name: calcipotriol
DrugBank: Calcipotriol (DB02300)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical calcipotriol 50 micrograms/g/ml solution
Trial: 11314240
Drug: Betamethasone valerate
RxNorm normalized name: Betamethasone Valerate
DrugBank: Betamethasone (DB00443)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Betamethasone valerate 1% lotion
Trial: 9007116
Drug: 24-hour infusion
RxNorm normalized name: respiratory syncytial virus pre-fusion F protein, recombinant 0.24 MG/ML [Arexvy]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 24-hour infusion of paclitaxel
Trial: 9007116
Drug: 3-hour infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 3-hour infusion of paclitaxel
Trial: 16381626
Drug: Every-3-week therapy
RxNorm normalized name: camphor
DrugBank: Camphor (DB01744)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Every-3-week therapy (200 mg/m2 paclitaxel, AUC 6 mg/mL/min carboplatin, trastuzumab initial 8 mg/kg, subsequent 6 mg/kg every 21 days for 8 cycles)
Trial: 16381626
Drug: Weekly therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekly therapy (80 mg/m2 paclitaxel, AUC 2 mg/mL/min carboplatin, trastuzumab initial 4 mg/kg, subsequent 2 mg/kg every 4 weeks for 6 cycles)
Trial: 16381626
Drug: Weekly therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekly therapy
Trial: 16381626
Drug: Every-3-week therapy
RxNorm normalized name: camphor
DrugBank: Camphor (DB01744)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Every-3-week therapy
Trial: 10428124
Drug: Enoxaparin (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoxaparin (30 mg every 12 hours)
Trial: 7555502
Drug: Diet alone
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diet alone (normal daily routine, 4,500 +/- 290 steps/day)
Trial: 6158861
Drug: Control (routine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (routine treatment with sedatives, bed rest, and magnesium sulfate)
Trial: 27593801
Drug: Conservative therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conservative therapy (Control)
Trial: 21864907
Drug: Controlled-release (CR)
RxNorm normalized name: Afeditab CR
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Controlled-release (CR) formulation, 600 mg single dose
Trial: 21864907
Drug: Immediate-release (IR)
RxNorm normalized name: IR-3535
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate-release (IR) formulation, 300 mg single dose
Trial: 21864907
Drug: Controlled-release (CR)
RxNorm normalized name: Afeditab CR
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Controlled-release (CR) formulation, 600 mg q12h multiple doses
Trial: 21864907
Drug: Immediate-release (IR)
RxNorm normalized name: IR-3535
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate-release (IR) formulation, 300 mg q6h multiple doses
Trial: 19702486
Drug: Atomoxetine 1.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atomoxetine 1.8 mg/kg per day
Trial: 19702486
Drug: Atomoxetine (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atomoxetine (0.5 mg/kg per day, 1.2 mg/kg per day, 1.8 mg/kg per day)
Trial: 15627870
Drug: Inhaled formoterol
RxNorm normalized name: formoterol Inhalation Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled formoterol (9 microg) twice a day
Trial: 15627870
Drug: Oral montelukast
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral montelukast (10 microg) once a day
Trial: 9412655
Drug: Cyclophosphamide 100
RxNorm normalized name: cyclophosphamide 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclophosphamide 100 mg/m2, Methotrexate 40 mg/m2, 5-Fluorouracil 600 mg/m2 (CMF)
Trial: 9412655
Drug: Epidoxorubicin 75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidoxorubicin 75 mg/m2 and Vincristine 0.75 mg/m2 (EV)
Trial: 9412655
Drug: Mitomycin-C 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mitomycin-C 10 mg/m2 and Vindesine 2 mg/m2 (MVs)
Trial: 8276739
Drug: Clomipramine at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clomipramine at top doses of 150 mg/day for 3 weeks
Trial: 28780551
Drug: Indigenous Counselling
RxNorm normalized name: Indigenous peanut oil
DrugBank: Peanut oil (DB13964)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indigenous Counselling And Nicotine (ICAN) QUIT in Pregnancy intervention including webinar training, educational resources, free oral nicotine replacement therapy (NRT), and audit and feedback.
Trial: 26121878
Drug: Tiotropium 18
RxNorm normalized name: TIOTROPIUM 18MCG CAP,INHL,6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiotropium 18 µg Qd
Trial: 26121878
Drug: Ipratropium 40
RxNorm normalized name: Ipratropium
DrugBank: Ipratropium (DB00332)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ipratropium 40 µg Qid
Trial: 25422827
Drug: Way Milano
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Way Milano implants
Trial: 25422827
Drug: Kentron implants
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Kentron implants
Trial: 12074370
Drug: Pharmacotherapy (PCT)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacotherapy (PCT)
Trial: 18358928
Drug: Perioperative chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perioperative chemotherapy with FOLFOX4 (6 cycles before and 6 cycles after surgery)
Trial: 18358928
Drug: Perioperative chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perioperative chemotherapy with FOLFOX4
Trial: 15737450
Drug: Step lengthening
RxNorm normalized name: PostDay One-Step
DrugBank: Levonorgestrel (DB00367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Step lengthening (twice a day)
Trial: 12534148
Drug: EGFR inhibitory
RxNorm normalized name: Egfr t790m inhibitor pf-06747775
DrugBank: Mavelertinib (DB16228)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EGFR inhibitory agents
Trial: 7863991
Drug: Antiarrhythmic drug
RxNorm normalized name: ANTIARRHYTHMICS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiarrhythmic drug therapy (amiodarone and sotalol)
Trial: 30325777
Drug: Antiretroviral treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiretroviral treatment interruption (ATI)
Trial: 27907921
Drug: DCF (docetaxel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DCF (docetaxel 70 mg/m2, cisplatin 70 mg/m2 on day 1, and 5‐fluorouracil 700 mg/m2 for 5 days) every 3 weeks
Trial: 27907921
Drug: ACF (adriamycin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACF (adriamycin 35 mg/m2, cisplatin 70 mg/m2 on day 1, and 5‐FU 700 mg/m2 for 7 days) every 4 weeks
Trial: 23114369
Drug: bivalent rLP2086
RxNorm normalized name: L1 protein, human papillomavirus type 16 vaccine
DrugBank: Human papillomavirus type 16 L1 capsid protein antigen (DB10301)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bivalent rLP2086 vaccine (20 µg, 60 µg, 200 µg)
Trial: 21861128
Drug: Thalidomide 400
RxNorm normalized name: Thalidomide
DrugBank: Thalidomide (DB01041)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Thalidomide 400 mg orally daily
Trial: 21861128
Drug: Irinotecan 350
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Irinotecan 350 mg/m2 intravenously every 3 weeks
Trial: 17004124
Drug: High-dose pegylated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose pegylated interferon alpha-2b plus ribavirin
Trial: 17004124
Drug: Low-dose pegylated
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose pegylated interferon alpha-2b plus ribavirin
Trial: 15266728
Drug: Pharmaceutical company
RxNorm normalized name: miconazole
DrugBank: Miconazole (DB01110)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Pharmaceutical company advertisements
Trial: 15266728
Drug: Scientific information
RxNorm normalized name: Inflammation OTC Bruise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Scientific information about depression and its treatment
Trial: 9212966
Drug: Heparin-bonded partial
RxNorm normalized name: SOY OIL,PARTIALLY HYDROGENATED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin-bonded partial cardiopulmonary bypass with nafamostat mesilate
Trial: 8428872
Drug: Desipramine (DMI)
DrugBank: Desipramine (DB01151)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Desipramine (DMI) at daily doses averaging 4 to 5 mg/kg
Trial: 24948414
Drug: 5% NaHCO3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% NaHCO3 solution at 45‐50°C
Trial: 11004053
Drug: Oral nifedipine
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral nifedipine (60 mg)
Trial: 11004053
Drug: Intravenous nimodipine
RxNorm normalized name: Nimodipine
DrugBank: Nimodipine (DB00393)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous nimodipine (30 microg x kg(‐1) x h(‐1) over 20 h)
Trial: 11004053
Drug: Intravenous magnesium
RxNorm normalized name: immunoglobulins, intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous magnesium sulfate (initial dose of 30 mg/kg followed by 10 mg x kg(‐1) x h(‐1) over 20 h)
Trial: 1754849
Drug: Nocloprost 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nocloprost 100 micrograms three times daily
Trial: 31935118
Drug: Omega-3 fatty
RxNorm normalized name: Omega-3 fatty acid
DrugBank: Omega-3 fatty acids (DB11133)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omega-3 fatty acids (4 capsules, 2.4 g daily for 12 weeks)
Trial: 23994918
Drug: Cytoflavin (20‐40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cytoflavin (20‐40 ml daily intravenously in drops for 10 days)
Trial: 22290679
Drug: Dexketoprofen 25
RxNorm normalized name: dexketoprofen 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexketoprofen 25 mg (Group D)
Trial: 22290679
Drug: Paracetamol 500
RxNorm normalized name: Paracetamol 500 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol 500 mg (Group P)
Trial: 19803237
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of Probenecid (on the basis of diet intervention)
Trial: 16891570
Drug: Paroxetine treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paroxetine treatment for 12 months
Trial: 16012271
Drug: Ziprasidone (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ziprasidone (40 to 80 mg BID)
Trial: 9856370
Drug: Lisinopril at
RxNorm normalized name: Lisinopril
DrugBank: Lisinopril (DB00722)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lisinopril at 20 mg with the addition of 12.5 or 25 mg hydrochlorothiazide as needed
Trial: 2797545
Drug: Fluoride rinse
RxNorm normalized name: ACT Fluoride Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoride rinse (0.2 percent sodium fluoride solution)
Trial: 344898
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of cyclophosphamide, methotrexate, 5‐fluorouracil, vincristine, and prednisone (repeated weekly treatment)
Trial: 344898
Drug: Intermittent treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent treatment of the same five drugs given in 5‐day courses every 4 weeks
Trial: 344898
Drug: Adriamycin as
RxNorm normalized name: Adriamycin
DrugBank: Doxorubicin (DB00997)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Adriamycin as a single agent (treatment every 3 weeks)
Trial: 3890229
Drug: Treatment effect
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment effect
Trial: 28504067
Drug: Manual therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manual therapy and exercise plus TrP dry needling (DN)
Trial: 28504067
Drug: Manual therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manual therapy and exercises
Trial: 23776118
Drug: Darbepoetin alfa
RxNorm normalized name: Darbepoetin Alfa
DrugBank: Darbepoetin alfa (DB00012)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Darbepoetin alfa (Darbe) 10 μg/kg, 1 time per week subcutaneously
Trial: 23776118
Drug: Placebo (sham
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (sham dosing)
Trial: 19036233
Drug: 200 mg/day
RxNorm normalized name: alpelisib 200 mg/day (200 mg x 1) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg/day of quetiapine fumarate
Trial: 19036233
Drug: 400 mg/day
RxNorm normalized name: ribociclib succinate 400 mg/day (200 mg x 2) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg/day of quetiapine fumarate
Trial: 19036233
Drug: Flexible dosing
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flexible dosing in Part 2
Trial: 10534145
Drug: Didanosine and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Didanosine and stavudine (100 + 10 mg, 100 + 20 mg, 100 + 40 mg, 200 + 20 mg, and 200 + 40 mg)
Trial: 10534145
Drug: High-dose subgroup
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose subgroup (arms 3, 4, and 5)
Trial: 10534145
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (didanosine and stavudine)
Trial: 1817622
Drug: Verapamil 0.01
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil 0.01 mg kg‐1 h‐1 (n = 12)
Trial: 6983207
Drug: Oral vitamin
RxNorm normalized name: vitamin A Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral vitamin D2 (450 IU) with 420 mg calcium daily
Trial: 6983207
Drug: Calcium alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium alone (420 mg)
Trial: 30597503
Drug: Fixed dose
RxNorm normalized name: Humalog Mix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed dose of 40 mg daily LMWH
Trial: 26445532
Drug: 250 mg
RxNorm normalized name: rutin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg Polygonum minus extract (PM) taken twice daily for 6 weeks
Trial: 22425113
Drug: Placebo treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo treatment with sham escalation
Trial: 19092364
Drug: Cytokine therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cytokine therapy (granulocyte colony-stimulating factor, erythropoietin, and stem cell factor)
Trial: 20364382
Drug: Cytokine therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cytokine therapy alone
Trial: 19092364
Drug: Various combinations
RxNorm normalized name: various combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Various combinations of cytokines with or without stem cell therapy
Trial: 17297068
Drug: Training +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Training + Medication (TM)
Trial: 17297068
Drug: Training +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Training + Incentive + Medication (TI+TM)
Trial: 9058557
Drug: Supportive-expressive (SE)
RxNorm normalized name: Selenomethionine Se-75
DrugBank: Selenomethionine Se-75 (DB09400)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supportive-expressive (SE) therapy
Trial: 11302268
Drug: Individual drug
RxNorm normalized name: chloroxylenol
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Individual drug counseling (IDC)
Trial: 3731684
Drug: prazosin (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: prazosin (1 mg t.i.d.)
Trial: 26999688
Drug: Antioxidants (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antioxidants (1 gram L-ascorbic acid per day)
Trial: 22921557
Drug: Home-based cyclergometer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Home-based cyclergometer training (30 min/day for 3 months, with monthly-supervised sessions)
Trial: 7865644
Drug: Plain aspirin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plain aspirin 300 mg
Trial: 7865644
Drug: Plain aspirin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plain aspirin 75 mg
Trial: 10102949
Drug: Enteric-coated aspirin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enteric-coated aspirin 300 mg
Trial: 7432659
Drug: Alpha-mercaptopropionylglycine (1500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alpha-mercaptopropionylglycine (1500 mg/day per os)
Trial: 27234460
Drug: Low polyunsaturated
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low polyunsaturated fat intake (1-4 g)
Trial: 27234460
Drug: High polyunsaturated
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High polyunsaturated fat intake (6-12 g)
Trial: 24794282
Drug: Verteporfin photodynamic
RxNorm normalized name: Verteporfin
DrugBank: Verteporfin (DB00460)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Verteporfin photodynamic therapy (PDT) combination therapy
Trial: 12419644
Drug: New formulation
RxNorm normalized name: TRIPROLIDINE HYDROCHLORIDE 1.25 mg in 1 mL ORAL SYRUP [HISTEX PD Drops New Formulation]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New formulation of ticlopidine hydrochloride (250mg)
Trial: 12419644
Drug: Reference formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference formulation Tiklid (250mg)
Trial: 7621491
Drug: Chewing gum
RxNorm normalized name: Chewing Gum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chewing gum containing 10 to 80 mg urea per piece, chewed for 10 minutes.
Trial: 7621491
Drug: Two pieces
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two pieces of gum containing 20 mg urea each, chewed for 10 minutes.
Trial: 7621491
Drug: Three pieces
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three pieces of gum containing 20 mg urea each, chewed one after the other (10 + 10 + 10 min).
Trial: 7226953
Drug: Inhaled distilled
RxNorm normalized name: petroleum distillate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled distilled water plus intramuscular (IM) saline solution
Trial: 7226953
Drug: Inhaled A
RxNorm normalized name: Inhaled allergen mix specific IgE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled A dose of atropine plus IM saline solution
Trial: 7226953
Drug: Inhaled distilled
RxNorm normalized name: petroleum distillate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled distilled water plus 0.35 mg IM atropine
Trial: 7226953
Drug: Inhaled A
RxNorm normalized name: Inhaled allergen mix specific IgE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled A dose of atropine plus 0.35 mg IM atropine
Trial: 7226953
Drug: Inhaled double
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled double the A dose plus IM saline solution
Trial: 29334921
Drug: Brief Social
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Brief Social Behaviour and Network Therapy (B‐SBNT) + Treatment as Usual (TAU)
Trial: 29334921
Drug: Personal Goal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Personal Goal Setting (PGS) + Treatment as Usual (TAU)
Trial: 27189286
Drug: Vitamin D
RxNorm normalized name: Vitamin D
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D supplementation (1000 IU during screening, median doses of 2000 IU daily)
Trial: 24219351
Drug: Cognitive behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behavioral therapy for psychosis
Trial: 17033909
Drug: Doxorubicin‐cisplatin (AP)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxorubicin‐cisplatin (AP) chemotherapy
Trial: 15702045
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose azithromycin (30 mg/kg)